摘要
目的:评价立体定向适形放疗联合经肝动脉栓塞化疗治疗原发性肝癌的临床疗效。方法:将62例中晚期肝癌患者分为R+T组(32例)与R组(30例),R+T组行立体定向适形放疗联合经导管肝动脉化疗栓塞术治疗,R组行单纯立体定向适形放疗,观察近期疗效与不良反应。结果:R+T组有效24例,有效率75.0%,R组有效15例,有效率50.0%,两者比较差异具有显著性,不良反应比较无显著性差异。结论:新型立体定向放疗联合TACE是治疗中晚期肝癌的有效手段。
Objective： To evaluate the effect of stereotactic conformal radiotherapy（SCRT） combined with tran- scatheter arterial chemoembolization for hepatocellular carcinoma. Methods： Total of 62 patients with advanced liver cancer were divided into RT group and R group,in RT group 32 cases treated by routine stereotactic conformal radio- therapy combined with transcatheter hepatic arterial chemoembolization therapy, in R group 30 cases treated by SCRT only. Results： In R ＋T group 24 cases were effective,efficient rate was 75.0% ,in R group 15 cases were effective and efficient rate was 50.0% ,the difference was significant, adverse reaction in 2 groups was similar. Conclusion： Stereotactic radiotherapy combined with TACE effective in the treatment of advanced liver cancer.
出处
《现代肿瘤医学》
CAS
2010年第5期962-963,共2页
Journal of Modern Oncology
